SFC Fluidics, Inc. is a biotechnology company is strcutured around development of miniaturized analytical and diagnostic platforms using microfluidic and detection technologies. One of the firm's products is a dual hormone patch pump intended to advance healthcare and improve quality of life through our enabling microfluidic technologies. The company's pump can control the delivery of both insulin and glucagon in a discreet patch pump that is the same size as the insulin-only patch pumps, enabling diabetic patients to improve their lifestyle and avoid complications. The firm's product categories comprise of various high performance components, such as microfluidic pumps, connectors, detector arrays, and Nanopipettes; instrument subsystems for solvent delivery, cell injection, electrochemical detection, chip-based chromatography, and on-chip separations; and portable benchtop and handheld platforms for in vitro diagnostics. SDFC also offers ePump, a solvent delivery system; QuickConnect, a microfluidic connector that enables instantaneous and automatically-aligned capillary tube connection; and EC-Reader, a handheld potentiostat to record electrochemical data. It also focuses on developing technologies, such as benchtop and handheld point-of-care and field diagnostics; carbon nanopipettes for simultaneous cellular injection and electrophysiology; lab-on-a-chip (analyte detection); and liquid chromatographic separations on-chip.
